Live Breaking News & Updates on Neumora Therapeutics

Stay updated with breaking news from Neumora therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Neumora Therapeutics (NASDAQ:NMRA) Stock Price Down 5.7%

Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) shares traded down 5.7% on Tuesday . The stock traded as low as $9.70 and last traded at $9.83. 262,511 shares were traded during trading, a decline of 45% from the average session volume of 478,619 shares. The stock had previously closed at $10.42. Wall Street Analyst […] ....

Canada , William-blair , Artal-group , Neumora-therapeutics-inc , Royal-bank , Jpmorgan-chase-co , Nasdaq , Pricet-rowe-associates-inc , Neumora-therapeutics , Get-free-report , Partners-management , Neumora-therapeutics-daily

Avidity Partners Management LP Purchases 190,632 Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA)

Avidity Partners Management LP lifted its position in shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Free Report) by 10.6% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,990,632 shares of the company’s stock after purchasing an additional 190,632 shares during the quarter. Avidity Partners […] ....

Canada , New-york , United-states , William-blair , Jpmorgan-chase-co , Sg-americas-securities , Nasdaq , Neumora-therapeutics-inc , Tower-research-capital , York-state-common-retirement-fund , Securities-exchange-commission , Royal-bank

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven brokerages that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average twelve-month […] ....

Canada , William-blair , Royal-bank , Jpmorgan-chase-co , Kennedy-capital-management , Nasdaq , Nan-fung-group-holdings-ltd , Neumora-therapeutics-company-profile , Artal-group , Neumora-therapeutics-inc , Pricet-rowe-associates-inc , Neumora-therapeutics

Neumora Therapeutics, Inc. (NASDAQ:NMRA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Neumora Therapeutics, Inc. (NASDAQ:NMRA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The […] ....

New-york , United-states , Canada , William-blair , Neumora-therapeutics-inc , Nasdaq , York-state-common-retirement-fund , Royal-bank , Jpmorgan-chase-co , Johnson , Citigroup-inc , Neumora-therapeutics

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH)

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH)
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Ji-nam , Castle-biosciences , Pacific-biosciences , Geoff-meacham , Integra-lifesciences , Robbie-marcus , Mineralys-therapeutics-inc , Vertex-pharmaceuticals , Cooper-co , Amylyx-pharmaceuticals-inc